Key facts
- This page summarizes Michael Heltzen's Form 4 filing for EXOZYMES INC. (EXOZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2025, 17:49.
Michael Heltzen - 02 Jul 2025 Form 4 Insider Report for EXOZYMES INC. (EXOZ)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- EXOZ
- Reported as of
- 02 Jul 2025
- Net transaction value
- +$10,629
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2025, 17:49:40 UTC
- Prior SEC filing
- 20 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Heltzen
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Heltzen filed Form 4 for EXOZYMES INC. (EXOZ) on 02 Jul 2025.
Change
- Previous filing in this sequence was filed on 20 Jun 2025.
- Current net transaction value: +$10,629.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002030840
Primary reporting owner
Heltzen Michael
- Relationship
- Chief Executive Officer
- Address
- C/O 750 ROYAL OAKS DRIVE,, SUITE 106, MONROVIA
- Signature
- /s/ Michael Heltzen
- Signature date
- 02 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXOZ
transaction
Common Stock
Purchase
- Transaction value
- $10,629
- Shares
- +1,040
- Change %
- +11%
- Price
- $10.22
- Shares after
- 10,629
- Date
- 02 Jul 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.